海外行/凝心聚力，康體生命美國波士頓分公司正式成立

為了實(shí)現加速響應客戶(hù)需求、“零距離”技術(shù)服務(wù)、無(wú)障礙溝通、縮短交付時(shí)間等目的，康體生命建立了一支本地化專(zhuān)業(yè)團隊，并整合、優(yōu)化當地資源，為客戶(hù)提供納米抗體和GPCR靶點(diǎn)膜蛋白的技術(shù)開(kāi)發(fā)方案。同時(shí)，分公司與當地多個(gè)合作伙伴建立深度協(xié)作關(guān)系，不斷開(kāi)拓北美市場(chǎng)?？刁w生命美國分公司負責人Mr.Du表示：“美國團隊能夠為北美乃至全球客戶(hù)提供優(yōu)質(zhì)、可靠、誠信、高效的GPCR納米抗體定制研發(fā)及功能驗證一站式解決方案平臺。

In order to achieve the purpose of faster response to customer needs, “zero distance” technical services, barrier-free communication. And shortening delivery time, AlpaLifeB has established a local & professional team. “The U.S. team can offer the worldwide market with high-quality products, realizable services, and efficient one-stop nanobody discovery platform. We are dedicated to support novel nanobody/VHH and GPCR-targeted drug development.” Said by Mr.Du, head of the AlpaLifeB Inc.